deltatrials
Completed PHASE3 NCT00049595

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma

BEACOPP (4 Cycles Escalated + 4 Cycles Baseline) Versus ABVD (8 Cycles) In Stage III & IV Hodgkin's Lymphoma

Sponsor: Australasian Leukaemia and Lymphoma Group

Conditions Lymphoma
Interventions ABVD regimen BEACOPP regimen bleomycin sulfate cyclophosphamide dacarbazine doxorubicin hydrochloride etoposide filgrastim pegfilgrastim prednisone procarbazine hydrochloride vinblastine sulfate vincristine sulfate
Updated 11 times since 2017 Last updated: Aug 4, 2025 Started: Aug 31, 2002 Primary completion: Jan 31, 2010

Listed as NCT00049595, this PHASE3 trial focuses on Lymphoma and remains completed. Sponsored by Australasian Leukaemia and Lymphoma Group, it has been updated 11 times since 2002, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jan 2023 — Dec 2023 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

▶ Show 6 earlier versions

  1. Mar 2021 — Jan 2023 [monthly]

    Active Not Recruiting PHASE3

    Status: Unknown Status → Active Not Recruiting

  2. Jan 2021 — Mar 2021 [monthly]

    Unknown Status PHASE3

  3. Aug 2019 — Jan 2021 [monthly]

    Unknown Status PHASE3

    Status: Active Not Recruiting → Unknown Status

  4. Jun 2018 — Aug 2019 [monthly]

    Active Not Recruiting PHASE3

  5. Aug 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  6. Jan 2017 — Aug 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Australasian Leukaemia and Lymphoma Group
  • European Organisation for Research and Treatment of Cancer - EORTC
  • Grup per l'Estudi dels Limfomes de Catalunya i Balears
  • Lymphoma Study Association
  • Lymphoma Trials Office
  • NCIC Clinical Trials Group
  • Nordic Lymphoma Group
Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

's-Hertogenbosch, Netherlands, Amersfoort, Netherlands, Amsterdam, Netherlands, Annecy, France, Antwerp, Belgium, Auckland, New Zealand, Barcelona, Spain, Bayonne, France, Besançon, France, Birmingham, United Kingdom and 103 more location s